Tianjin Lisheng Pharmaceutical Co.,Ltd. (SHE:002393)

Market Cap	4.06B -34.0%
Revenue (ttm)	1.30B -1.6%
Net Income	151.69M -64.3%
EPS	0.49 -64.6%
Shares Out	308.12M
PE Ratio	26.96
Forward PE	n/a
Dividend	1.00 (7.59%)
Ex-Dividend Date	Apr 28, 2026

Volume	2,600,724
Open	13.79
Previous Close	13.19
Day's Range	12.70 - 13.79
52-Week Range	12.75 - 20.35
Beta	-0.08
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 26, 2026

About SHE:002393

Tianjin Lisheng Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of pharmaceutical products in China and internationally. The company offers pharmaceutical, traditional Chinese medicine, and antibiotic products in various forms, such as oral solid dosage forms, soft capsules, sterile preparations, and raw materials primarily for cardiovascular and digestive system applications. Its products also include Shoubishan capsules, Jiayindapamide tablets, Sanyu Zhengtong tablets, Xifuni cefdinir dispersible tablets,...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1951
• Employees: 1,605
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002393

Financial Performance

In 2025, SHE:002393's revenue was 1.39 billion, an increase of 4.18% compared to the previous year's 1.34 billion. Earnings were 416.28 million, an increase of 125.59%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 23, 2026

Data Sources Report a data error